Overexpression of this gene at the protein level has also been detected in breast cancer by immunohistochemistry, with POMK being found both N-glycosylated (in a process regulated by ribophorin 1, or RPN1) and lacking N-glycosylation in both tumor and healthy tissues. This evidence concerns the gene RPN1 and breast carcinoma.